Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients

NCT00467311 · clinicaltrials.gov ↗
COMPLETED
Status
66
Enrollment
OTHER_GOV
Sponsor class

Conditions

Sponsor

National Heart Institute, Mexico